Comparison of the Alpha-2 Agonists for Prevention of Intraocular Pressure Elevation After Selective Laser Trabeculoplasty

Status unconfirmed · Not applicable

Conditions studied: Glaucoma, Ocular Hypertension

In brief

The purpose of the study is to compare the safety and efficacy of two drops used to lower eye pressure when given prior to a glaucoma laser procedure.

Key facts

Study ID

NCT00567411

Run by

Walter Reed Army Medical Center

People needed

43

Starts

2006-08-01

Expected to finish

2009-06-01

Last updated by the study team

2007-12-05

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• male or female, at least 18 years of age
• Open Angle Glaucoma with inadequate intraocular pressure (IOP) control or evidence of progression (based on optic nerve head appearance and/or visual field changes) despite current medical therapy
• Ocular Hypertension requiring lowering of IOP
• ability to understand and provide informed consent to participate in this study and willingness to follow study instructions and likely to complete all required visits

You may not qualify if…

• inability to understand and provide informed consent to participate in this study
• inability/unwillingness to follow study instructions and complete all required visits
• Documented allergy to either brimonidine or iopidine
• Angle Closure Glaucoma
• Congenital/Juvenile Glaucoma
• Neovascular Glaucoma
• Active uveitis

Where it is running

• Walter Reed Army Medical Center — Washington D.C., District of Columbia, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.